Folate-chitosan-gemcitabine core-shell nanoparticles targeted to pancreatic cancer

Chinese Journal of Cancer Research

Volumn 25, Issue 5, 2013, Pages 527-535

  Zhou, Jiahua ^a   Wang, Junying ^a   Xu, Qian ^a   Xu, Shi ^a   Wen, Jin ^a   Yu, Zeqian ^a   Yang, Detong ^a  

^a SOUTHEAST UNIVERSITY   (China)

Author keywords

Folate receptor; Gemcitabine; Pancreatic cancer; Targeted nanoparticle

Indexed keywords

CHITOSAN; FOLATE RECEPTOR; GEMCITABINE; ISOTHIOCYANIC ACID; NANOPARTICLE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER CHEMOTHERAPY; CANCER INHIBITION; CANCER PROGNOSIS; CELL PROLIFERATION; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; ELECTROSPRAY; FEMALE; FLUORESCENCE MICROSCOPY; HELA CELL LINE; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; MALE; MOUSE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PANCREAS CANCER; PANCREATIC CANCER CELL LINE; PROTEIN EXPRESSION; TREATMENT DURATION;

EID: 84901601304     PISSN: 10009604     EISSN: 19930631     Source Type: Journal    
DOI: 10.3978/j.issn.1000-9604.2013.09.04     Document Type: Article

References (23)

1. Siegel R, Naishadham D, Jemal A, et al. Cancer Statistics, 2013. CA Cancer J Clin 2013;63:11-30.
2. Zhang DS, Wang DS, Wang ZQ, et al. Phase I/II study of albumin-bound nab-paclitaxel plus gemcitabine administered to Chinese patients with advanced pancreatic cancer. Cancer Chemother Pharmacol 2013;71:1065-72.
3. Xu B, Zheng WY, Jin DY, et al. Treatment of pancreatic cancer using an oncolytic virus harboring the lipocalin-2 gene. Cancer 2012;118:5217-26.
4. Reid JM, Qu W, Safgren SL, et al. Phase I trial and pharmacokinetics of Gemcitabine in children with advanced solid tumors. J Clin Oncol 2004;22:2445-51. (Pubitemid 41115403)
5. Wang YX. Superparamagnetic iron oxide based MRI contrast agents: Current status of clinical application. Quant Imaging Med Surg 2011;1:35-40.
6. Leamon CP, Reddy JA. Folate-targeted chemotherapy. Adv Drug Deliv Rev 2004;56:1127-41. (Pubitemid 38496512)
7. Zhao H, Yung LY. Selectivity of folate conjugated polymer micelles against different tumor cells. Int J Pharm 2008;349:256-68. (Pubitemid 350299702)
8. Low PS, Henne WA, Doorneweerd DD. Discovery and development of folic-acid-based receptor targeting for Imaging and therapy of cancer and inflammatory diseases. Acc Chem Res 2008;41:120-9.
9. Low PS, Kularatne SA. Folate-targeted therapeutic and imaging agents for cancer. Curr Opin Chem Biol 2009;13:256-62.
10. Zhao H, Yung LY. Addition of TPGS to folate-conjugated polymer micelles for selective tumor targeting. J Biomed Mater Res A 2009;91:505-18.
11. You J, Li X, de Cui F, et al. Folate-conjugated polymer micelles for active targeting to cancer cells: preparation, in vitro evaluation of targeting ability and cytotoxicity. Nanotechnology 2008;19:045102.
12. Han X, Liu J, Liu M, et al. 9-NC-loaded folate-conjugated polymer micelles as tumor targeted drug delivery system: Preparation and evaluation in vitro. Int J Pharm 2009;372:125-31.
13. Liu Y, Li K, Pan J, et al. Folic acid conjugated nanoparticles of mixed lipid monolayer shell and biodegradable polymer core for targeted delivery of Docetaxel. Biomaterials 2010;31:330-8.
14. Benepal TS, Judson I. ZD9331: discovery to clinical development. Anti-cancer Drugs 2005;16:1-9.
15. Xu S, Xu Q, Zhou J, et al. Preparation and characterization of folate-chitosan -gemcitabine core-shell nanoparticles for potential tumor-targeted drug delivery. J Nanosci Nanotechnol 2013;13:129-38.
16. Sudimack J, Lee RJ. Targeted drug delivery via the folate receptor. Adv Drug Deliv Rev 2000;41:147-62. (Pubitemid 30122955)
17. Hilgenbrink AR, Low PS. Folate receptor-mediated drug targeting: From therapeutics to diagnostics. J Pharm Sci 2005;94:2135-64.
18. Agnihotri SA, Mallikarjuna NN, Aminabhavi TM. Recent advances on chitosan-based micro- and nanoparticles in drug delivery. J Control Release 2004;100:5-28. (Pubitemid 39445982)
19. Zhou J, Yu Z, Zhao S, et al. Lentivirus-based DsRed-2-transfected pancreatic cancer cells for deep in vivo imaging of metastatic disease. J Surg Res 2009;157:63-70.
20. Parker N, Turk MJ, Westrik E, et al. Folate receptor expression in carcinomas and normal tissues determined by a quantitative radioligand binding assay. Anal Biochem 2005;338:284-93. (Pubitemid 40312593)
21. Zheng HM. Expression of molealar imaging marker folate receptor alpha in pancreatic cancer and its significance. J Shandong Univ (Health Sciences) 2010;48:83-5.
22. Vandana M, Sahoo SK. Long circulation and cytotoxicity of PEGylated gemcitabine and its potential for the treatment of pancreatic cancer. Biomaterials 2010;31:9340-56.
23. Bergman AM, Adema AD, Balzarini J, et al. Antiproliferative activity, mechanism of action and oral antitumor activity of CP-4126, a fatty acid derivative of Gemcitabine, in vitro and in vivo tumor models. Invest New Drugs 2011;29:456-66.